Sabra Health Care REIT, Inc.
SBRAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Sabra Health Care REIT, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 14 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Allianz Asset Management GmbH | 2026-03-31 | 835,733 | $16.1M | SEC filing |
| MTM Investment Management, LLC | 2026-03-31 | 21 | $404 | SEC filing |
| HARBOUR INVESTMENTS, INC. | 2026-03-31 | 2,281 | $43.9K | SEC filing |
| NBC SECURITIES, INC. | 2026-03-31 | 1,213 | $23.3K | SEC filing |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2026-03-31 | 1,558,853 | $30M | SEC filing |
| AMERICAN NATIONAL BANK & TRUST | 2026-03-31 | 6 | $114 | SEC filing |
| SECURIAN ASSET MANAGEMENT, INC | 2026-03-31 | 18,585 | $357K | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 2,242,243 | $43.1M | SEC filing |
| ST GERMAIN D J CO INC | 2026-03-31 | 750 | $14.4K | SEC filing |
| Focus Partners Wealth | 2026-03-31 | 25,963 | $499K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 8,278 | $159K | SEC filing |
| CHILTON CAPITAL MANAGEMENT LLC | 2026-03-31 | 14,612 | $281K | SEC filing |
| Argent Trust Co | 2026-03-31 | 17,017 | $327K | SEC filing |
| PRIVATE TRUST CO NA | 2026-03-31 | 621 | $11.9K | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 12,685 | Not shown | SEC filing |
| Whipplewood Advisors, LLC | 2026-03-31 | 73 | $1.4K | SEC filing |
| FRANKLIN RESOURCES INC | 2026-03-31 | 390,431 | $7.51M | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 49,483 | $952K | SEC filing |
| Delta Investment Management, LLC | 2026-03-31 | 11,500 | $221K | SEC filing |
| Penserra Capital Management LLC | 2026-03-31 | 78,485 | Not shown | SEC filing |
- Each value is checked against Sabra Health Care REIT, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Sabra Health Care REIT, Inc.'s share price.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-25 | FLORES JESSICA · Executive VP & CAO | Common Stock | S — Open market or private sale | −15,231 | 19.86 | SEC filing |
| 2025-05-20 | FOSTER MICHAEL J · Director | Common Stock | S — Open market or private sale | −11,000 | 18.22 | SEC filing |
| 2025-02-24 | Cusack Catherine · Director | Common Stock | P — Open market or private purchase | +1,500 | 15.92 | SEC filing |
| 2025-02-21 | Cusack Catherine · Director | Common Stock | P — Open market or private purchase | +1,000 | 16.44 | SEC filing |
| 2024-05-22 | Cusack Catherine · Director | Common Stock | P — Open market or private purchase | +7,000 | 14.43 | SEC filing |
| 2024-05-14 | FOSTER MICHAEL J · Director | Common Stock | S — Open market or private sale | −10,000 | 14.68 | SEC filing |
| 2023-09-01 | Costa Michael Lourenco · Executive VP, CFO & Secretary | Common Stock | P — Open market or private purchase | +1,947 | 12.63 | SEC filing |
Showing 7 of 7 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | Malehorn Jeffrey A. · Director | Common Stock | A — Grant, award, or other acquisition | +8,310 | SEC filing |
| 2026-06-17 | Cusack Catherine · Director | Common Stock | A — Grant, award, or other acquisition | +8,310 | SEC filing |
| 2026-06-17 | KATZMANN LYNNE S · Director | Common Stock | A — Grant, award, or other acquisition | +8,310 | SEC filing |
| 2026-06-17 | Kono Ann · Director | Common Stock | A — Grant, award, or other acquisition | +8,310 | SEC filing |
| 2026-06-17 | FOSTER MICHAEL J · Director | Common Stock | A — Grant, award, or other acquisition | +8,310 | SEC filing |
| 2026-06-17 | Barbarosh Craig A. · Director | Common Stock | A — Grant, award, or other acquisition | +8,310 | SEC filing |
| 2026-05-29 | FOSTER MICHAEL J · Director | Common Stock | G — Bona fide gift | −500 | SEC filing |
| 2026-05-29 | Cusack Catherine · Director | Common Stock | A — Grant, award, or other acquisition | +817 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.